Natalie Ricciardi, PhD

Senior Analyst

Dr. Ricciardi joined inThought in 2024 after receiving her PhD in Biochemistry and Molecular Biology from the University of Miami (UM) with a focus in preclinical Alzheimer’s disease drug discovery and basic mechanisms of memory formation. Training at the intersection of biochemistry and psychiatry under Dr. Claes Wahlestedt, she became a multidimensional investigator with a skillset that spans epigenetics, exercise physiology, DNA damage and repair, next-generation sequencing technologies, oligonucleotide therapeutics, and rare diseases.
 
During her PhD, Dr. Ricciardi co-founded the Florida chapter of Nucleate, a biotech nonprofit democratizing access to biotech entrepreneurship for life science founders. With her leadership team, she created Florida’s only inter-university life science organization, connecting early-stage founders and trainees to workforce development and entrepreneurial opportunities across the state and increasing the quality and visibility of life science talent produced in Florida. During this time, she also completed the Research Commercialization Fellowship at the UM Office of Technology Transfer and Nucleate’s Business Development Fellowship in collaboration with Genentech. These experiences have helped Dr. Ricciardi develop a unique ability to generate strategic, interdisciplinary partnerships to solve many of the hurdles associated with biotech entrepreneurship from technical strategy and talent sourcing to economic development and government support.
Linkedin

inThought Research empowers biopharma leaders with comprehensive strategic insights. We combine Wall Street financial acumen and swiftness, scientific expertise, and advanced AI analytics to navigate the complex landscape of drug development.

Linkedin
Quick Links
Get In Touch
Our Family Of Companies​
inThought Labs logo

Privacy Policy

Terms of Service

Services

Vulnerability

© 2025 inThought Research. All Rights Reserved.

Contact us

Learn how inThought Labs can simplify your life and empower your team with expert consultants and our cloud-based system, inVision.

Chris Martin

President

As the president of inThought Labs, Chris is focused on constantly improving inVision, the leading competitive and market intelligence platform for the biopharmaceutical industry, to better meet the changing needs of clients.

 

With 20 years of experience in roles being a consumer of market and competitive information, Chris understands the needs and priorities of clients. Chris was a senior principal and co-founder of inThought, a life science consulting, market research, and analytics firm. Collaborating with Ben Weintraub, Chris also co-founded BiotechTracker, an online tool for investors and precursor to inVision. Previous to inThought, he was a healthcare analyst and co-portfolio manager at two investment firms. Chris served in health care policy roles at the White House Office of Management and Budget. These roles included Medicare Desk Officer at the Office of Information and Regulatory Affairs, where he was responsible for providing recommendations to senior White House policy officials on healthcare policies and regulations.

 

Chris has a Master in Business Administration from Harvard Business School, a Master in Engineering from Villanova University, and a Bachelor of Science in Engineering from Cornell University. Prior to attending Harvard Business School, Chris served on two U.S. Navy nuclear submarines and at the Pentagon.